NASDAQ:XRTX Xyratex (XRTX) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.72▼$2.0450-Day Range N/A52-Week Range N/AVolume62,050 shsAverage Volume172,312 shsMarket Capitalization$3.50 millionP/E RatioN/ADividend YieldN/APrice Target$14.00 Stock AnalysisStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesShort InterestTrendsStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesShort InterestTrends Get Xyratex alerts: Email Address Xyratex MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside700.0% Upside$14.00 Price TargetShort InterestHealthy3.37% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.06 out of 5 stars 3.5 Analyst's Opinion Consensus RatingXyratex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageXyratex has received no research coverage in the past 90 days.Read more about Xyratex's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.37% of the float of Xyratex has been sold short.Short Interest Ratio / Days to CoverXyratex has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Xyratex has recently increased by 4,031.82%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldXyratex does not currently pay a dividend.Dividend GrowthXyratex does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for XRTX. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for Xyratex this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Xyratex insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.90% of the stock of Xyratex is held by insiders.Percentage Held by InstitutionsOnly 0.23% of the stock of Xyratex is held by institutions.Read more about Xyratex's insider trading history. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Xyratex is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Xyratex is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioXyratex has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Xyratex's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Xyratex Stock (NASDAQ:XRTX)Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers. Its product and solution portfolio for the enterprise data storage industry includes storage enclosures, integrated application platforms and high performance computing (HPC) data storage solutions. In April 2014, Seagate Technology PLC completed the acquisition of Xyratex Ltd.Read More Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. XRTX Stock News HeadlinesMay 20, 2024 | msn.comXRTX Stock Earnings: XORTX Therapeutics Reported Results for Q1 2024May 17, 2024 | globenewswire.comXORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPOJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.April 30, 2024 | globenewswire.comXORTX Reprices Warrants Issued in Connection with Previous Private PlacementsApril 26, 2024 | ca.finance.yahoo.comXORTX Therapeutics Inc. (XRTX.V)April 22, 2024 | globenewswire.comXORTX Announces Publication of Key Research in ADPKDApril 8, 2024 | globenewswire.comXORTX Welcomes New Member to the Board of DirectorsApril 5, 2024 | morningstar.comXORTX Therapeutics Inc XRTXJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.April 1, 2024 | nasdaq.comXORTX Therapeutics Inc. Common Stock (XRTX)March 27, 2024 | globenewswire.comXORTX Announces New Clinical Advisory Board MemberMarch 19, 2024 | finance.yahoo.comXORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical TrialMarch 19, 2024 | globenewswire.comXORTX Highlights Achievements of 2023 and Preparation for Registration Clinical TrialMarch 11, 2024 | finance.yahoo.comXORTX Reprices Warrants Issued in Connection with Previous Private PlacementsMarch 4, 2024 | globenewswire.comXORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsFebruary 15, 2024 | finance.yahoo.comXORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsFebruary 2, 2024 | finance.yahoo.comXORTX Files an Amended and Restated Prospectus Supplement for the Offering of UnitsJanuary 15, 2024 | finance.yahoo.comXORTX Announces $2 Million Public OfferingSee More Headlines Receive XRTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Xyratex and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today7/26/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:XRTX CUSIPN/A CIK1284823 Webwww.xyratex.com Phone+44-23-92496000FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$14.00 High Stock Price Target$14.00 Low Stock Price Target$14.00 Potential Upside/Downside+700.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.3401) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,160,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-135.54% Return on Assets-107.64% Debt Debt-to-Equity RatioN/A Current Ratio13.67 Quick Ratio13.67 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.32 per share Price / Book0.75Miscellaneous Outstanding Shares2,000,000Free Float1,861,000Market Cap$3.50 million OptionableNot Optionable Beta0.68 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesErnest J. Sampias (Age 62)Interim Chief Executive Officer, Director Richard Pearce (Age 42)Chief Financial Officer, Director Kenneth Todd Gresham (Age 55)Senior Vice President - Marketing, Sales and Field Support Doug Inamine (Age 47)Senior Vice President - Human Resources Luciano Marinaccio (Age 47)Senior Vice President - Global Operations Ed Prager (Age 48)Senior Vice President - Research and Development Ahmed Shihab (Age 42)Senior Vice President - Business Line Management Jonathan Brooks (Age 61)Non-Executive Independent Chairman of the Board Vadim Perelman (Age 33)Director Ken TraubDirectorMore ExecutivesKey CompetitorsChemomab TherapeuticsNASDAQ:CMMBKiora PharmaceuticalsNASDAQ:KPRXBriaCell TherapeuticsNASDAQ:BCTXUniverse PharmaceuticalsNYSE:UPCCan-Fite BioPharmaNYSE:CANFView All Competitors XRTX Stock Analysis - Frequently Asked Questions How were Xyratex's earnings last quarter? Xyratex Ltd (NASDAQ:XRTX) released its earnings results on Wednesday, May, 15th. The technology company reported ($1.24) earnings per share (EPS) for the quarter. When did Xyratex's stock split? Shares of Xyratex reverse split on Friday, November 10th 2023. The 1-9 reverse split was announced on Friday, November 10th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 11 shares after the split. What other stocks do shareholders of Xyratex own? Based on aggregate information from My MarketBeat watchlists, some other companies that Xyratex investors own include Encore Wire (WIRE), Vishay Intertechnology (VSH), Skyworks Solutions (SWKS), SandRidge Energy (SD), NVIDIA (NVDA), Marvell Technology (MRVL) and MIPS Technologies (MIPS). This page (NASDAQ:XRTX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xyratex Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Xyratex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
